Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

161.74 -7.63 (-4.51%)

Streaming Delayed Price Updated: 2:27 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma ↗

March 03, 2022

The U.S. District Court for the Western District of Texas dismissed a lawsuit filed by Canadian cannabis giant C...

Via Benzinga

Expert Ratings For Jazz Pharmaceuticals ↗

March 02, 2022

Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...

Via Benzinga

Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results ↗

March 01, 2022

Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma...

Via Benzinga

Jazz Pharmaceuticals: Q4 Earnings Insights ↗

March 01, 2022

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Analyst Ratings For Jazz Pharmaceuticals ↗

December 20, 2021

Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed th...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

This Company's 18-Month CBD Stability Achievement Could Hint Towards Expansion Goals As It Plans To Release First Commercial UST System In 2022 ↗

February 10, 2022

Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Does This Company's Recent CBD Breakthrough Earn It A Spot In The Guinness World Records? ↗

February 04, 2022

Photo by CBD Infos on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

New Psychedelics ETF Launches On NYSE Arca ↗

February 02, 2022

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...

Via Benzinga

The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It? ↗

January 28, 2022

MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list.

Via Benzinga

Jim Cramer Shares His Thoughts On ArcBest, Ulta Beauty And More ↗

January 27, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes ArcBest Corporation (NASDAQ:

Via Benzinga

Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest ↗

January 19, 2022

The deal includes a CVS tied to Fintepla's next potential approval.

Via Investor's Business Daily

Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026 ↗

January 14, 2022

As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised...

Via Benzinga

60 Biggest Movers From Yesterday ↗

January 11, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...

Via Benzinga

2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)

January 06, 2022

Via AB Newswire

A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report ↗

January 04, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year....

Via Benzinga

5 Stocks To Watch For January 4, 2022 ↗

January 04, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects SMART Global Holdings, Inc. (NASDAQ: SGH) to report quarterly earnings at $2.00 per share on...

Via Benzinga

Ten Biggest Weed Stories Of 2021: Big Pharma, Delta-8, Tech, Silicon Valley, MSOs, Politics And More ↗

January 03, 2022

This article was originally published on WeedWeek and appears here with...

Via Benzinga

5 Themes That Will Drive The Cannabis Sector Higher In 2022 ↗

December 31, 2021

2021 was a period of strong growth for the global cannabis market and we expect the cannabis sector to build on its success in 2022.

Via Talk Markets

Jazz Pharmaceuticals Begins Enrollment For Clinical Trial To Evaluate JZP150 For Adults With PTSD ↗

December 30, 2021

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical trial evaluating the safety and...

Via Benzinga

Jazz Pharmaceuticals: Debt Overview ↗

December 30, 2021

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) rose by 0.8% on Wednesday. Before having a look at the importance of debt, let us look at how much debt Jazz Pharmaceuticals...

Via Benzinga

Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table ↗

December 23, 2021

This article was originally published on The Bluntness, and ...

Via Benzinga

A Look Into Jazz Pharmaceuticals Debt ↗

December 20, 2021

Over the past three months, shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) fell by 6.85%. Before we understand the importance of debt, let us look at how much debt Jazz...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

December 20, 2021

JP Morgan raised the price target on Public Storage (NYSE:

Via Benzinga

The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More ↗

December 17, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021.

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

December 17, 2021

Piper Sandler boosted Accenture plc (NYSE:ACN) pric...

Via Benzinga

7 Meme Stocks to Buy on Their Market Slump and Rebound ↗

December 14, 2021

These seven meme stocks suffered downturns recently, but they have the appropriate catalysts to move upward in the near term.

Via InvestorPlace

Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack ↗

December 14, 2021

Photo by Michael Longmire on...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.